German working group of resident doctors in the care of HIV-infected people

from Wikipedia, the free encyclopedia

The German Association of Resident Doctors in the Care of HIV-Infected People V. (DAGNÄ e.V.) was founded in 1990 in Aachen and is a non-profit association that supports all established HIV therapists and their patients nationwide . Various training and research programs ensure that members diagnose and treat people infected with HIV and AIDS in accordance with the latest standards. The focus is on the flow of information and interdisciplinary cooperation and compliance with quality standards through HIV contracts and therapy guidelines. The dagnä has been based in Berlin since 2009 .

Members

The DAGNÄ e. V. represents all resident HIV therapists, i.e. HIV specialist practices, integration practices, HIV co-treatmenters and doctors who need support in the care of HIV and AIDS patients. Almost all HIV focus centers as well as over 50% of the co-treatmenters are available through DAGNÄ e. V. networked.

aims

The DAGNÄ e. V. would like to achieve an optimized care concept for HIV and AIDS in Germany & comprehensive quality assurance in the HIV area. The work of DAGNÄ e. V. concentrates on current diagnosis and therapy options as well as social and legal changes.

Health policy work

In the area of ​​health policy, DAGNÄ has implemented the following points, among others in cooperation with other institutions:

  1. Extension of the criteria catalog for the so-called chronicler regulation
  2. OTC drug list for necessary HIV therapeutics
  3. Statements on the off-label use problem with HIV
  4. German guidelines on adherence
  5. Certificate for specialized HIV practices
  6. Recognition criteria for specialized practices
  7. Health training for patients
  8. AIDS surcharge numbers in several health insurance associations
  9. HIV contracts and AIDS agreements with health insurance companies according to medical developments
  10. Exceptions to partial budgets
  11. quick access to new medicines
  12. Viral load determination in the EBM (uniform assessment standard)
  13. Resistance testing in the EBM
  14. national and European guidelines and compendia
  15. comprehensive HIV training structure
  16. Therapy recommendations for various HIV-associated diseases

Guidelines and recommendations

In cooperation with other AIDS societies, a number of guidelines have been developed, such as: For example, the German-Austrian recommendations for antiretroviral therapy for HIV infection , for HIV therapy during pregnancy and for the diagnosis and treatment of HIV-discordant couples who wish to have children.

research

The medical research projects of DAGNÄ eV deal with the following topics:

  • Side effects of antiretroviral therapy: DAGNÄ has completed and presented a long-term, multi-center project on lipodystrophy . Further projects dealing with side effects have been initiated. Including:
    • Osteoporosis : Parallel to the continuation of LipART, there is a possibility to evaluate changes in bone metabolism in relation to ART as separate analyzes.
    • Lipodystrophy : continued - The longitudinal section of the LipART introduces some new parameters, including: a. Bring DEXA and sober lipid levels, for improved diagnosis and evaluation. A number of sub-studies can also be included.
    • Side effects of HIV protease inhibitors
  • Primary infection : DAGNÄ would like to record these relevant patients as early as possible with an evaluation of the acute primary infection. In addition, the association should make a therapy recommendation.
  • HIV and oncology : This project includes the establishment of a DAGNÄ oncology working group, the collection of current epidemiological data and the collaboration between HIV practices and oncologists with the aim of improving therapy recommendations.
  • Therapy safety and adherence: a regional pilot study on therapy safety will be initiated. The patient's adherence to antiretroviral therapy is evaluated by comparing the prescription.

Web links